Dizhe Pharmaceutical (688192.SH) released its 2023 annual performance report. During the reporting period, the company achieved an operating income of 9...
According to Zhitong Finance App News, Dizhe Pharmaceutical (688192.SH) released its 2023 annual performance report. During the reporting period, the company achieved operating income of 91.2886 million yuan; net loss attributable to shareholders of listed companies of 1,108 billion yuan; net loss attributable to shareholders of listed companies after deducting non-recurring profit and loss of 1,161 million yuan; and a basic loss of 2.72 yuan per share.